Research into conditions like strokes, Alzheimer’s disease, schizophrenia and cancer will be significantly advanced by a unique collaboration between six Scottish universities, launched this week.
SINAPSE (The Scottish Imaging Network: A Platform for Scientific Excellence) will bring together experts from the universities of Aberdeen, Dundee, Edinburgh, Glasgow, Stirling, and St Andrews to form the world's first virtual clinical imaging laboratory.
The £40m initiative will focus primarily on imaging of the brain, using state-of-the-art technology that includes magnetic resonance imaging (MRI) and positron emission tomography (PET).
Pooling these resources across Scotland, the partnership will combine the collection of different types of brain information such as structure, function and brain waves, and develop new radioactive tracers for different diseases. These data will further research into strokes, dementia, diabetes, cancer, and mental health.
The SINAPSE collaboration will:
· Facilitate the recruitment of international leading researchers to Scotland, and retain the best young graduates from Scottish universities
· Enhance research by enabling wider patient participation in clinical trials, and strategic leadership in the dissemination of best research practice
· Fund five new chairs, 17 mid-level posts, 24 PhDs, and assorted equipment to enhance research and graduate training
SINAPSE has secured £6.3m from the Scottish Funding Council (including support from the Chief Scientist Office), and £35m investment from the partner universities. It will initially run for the next five years.
Joanna Wardlaw, Professor of Applied Neuroimaging and Honorary Consultant Neuroradiologist at the University of Edinburgh said: "SINAPSE is the first such alliance in Scottish medicine, and we are proud that universities across Scotland have come together to further our understanding of conditions like stroke and dementia using imaging. Several key advances in medical imaging originated in Scotland, so we are continuing what is a strong research tradition."
"This new collaboration will be internationally unique and will ensure an enhanced and competitive presence for Scotland in international research. Working together, we can make new discoveries for the benefit of all patients, which would be hard to make by working alone."
Dr Alison Murray, who together with Dr Andy Welch is heading up the University of Aberdeen's involvement, said: "Universities in Scotland are committed to translating findings from basic biomedical research into positive outcomes for patients and this boost for brain imaging research will help us achieve these goals faster.
"Imaging technology is being used by Scottish researchers to study a wide range of conditions which include brain ageing, stroke, autism, Parkinson's and Alzheimer's diseases. We very much look forward to collaborating with colleagues at the five other institutions in a partnership which will be of great benefit to patients in Scotland and beyond."